SolventumSOLV
About: Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Employees: 22,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
43% more first-time investments, than exits
New positions opened: 146 | Existing positions closed: 102
29% more capital invested
Capital invested by funds: $5.68B [Q2] → $7.35B (+$1.67B) [Q3]
22% more funds holding in top 10
Funds holding in top 10: 9 [Q2] → 11 (+2) [Q3]
3% more funds holding
Funds holding: 887 [Q2] → 917 (+30) [Q3]
1.37% less ownership
Funds ownership: 62.22% [Q2] → 60.85% (-1.37%) [Q3]
26% less call options, than puts
Call options by funds: $48M | Put options by funds: $64.8M
59% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 426
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Mizuho Steven Valiquette 60% 1-year accuracy 3 / 5 met price target | 6%downside $70 | Neutral Initiated | 4 Dec 2024 |
Financial journalist opinion
Based on 3 articles about SOLV published over the past 30 days









